ADC Biotechnology
Saint Asaph
About ADC Biotechnology
ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.6M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2018)
- Website: adcbio.com
- Phone: +44 (0)7739 754337
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/adc-biotechnology-194535 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.